- Filed
- Apr 26, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | FY 2023 · Dec 31, 2022 | $864.26M |
| Cash And Equivalents | FY 2023 · Dec 31, 2022 | $6.03B |
| Stockholders Equity | FY 2023 · Dec 31, 2022 | $5.72B |
| Current Liabilities | FY 2023 · Dec 31, 2022 | $6.94B |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $11.19B |
| Current Assets | FY 2023 · Dec 31, 2022 | $12.69B |
| Total Assets | FY 2023 · Dec 31, 2022 | $17B |
| Shares Diluted | FY 2023 · Dec 31, 2021 | 532.71M sh |
| Capex | FY 2023 · Dec 31, 2021 | $772.18M |
| Operating Cash Flow | FY 2023 · Dec 31, 2021 | $208.65M |
| Eps Diluted | FY 2023 · Dec 31, 2021 | −$3.84 |
| Eps Basic | FY 2023 · Dec 31, 2021 | −$3.84 |
| Sga Expense restated | FY 2023 · Dec 31, 2021 | $987.87M |
| Rd Expense | FY 2023 · Dec 31, 2021 | $831.7M |
| Net Income | FY 2023 · Dec 31, 2021 | −$2.05B |
| Operating Income | FY 2023 · Dec 31, 2021 | −$1.58B |
| Gross Profit | FY 2023 · Dec 31, 2021 | $3.9B |
| Revenue | FY 2023 · Dec 31, 2021 | $9.96B |